Generics need patent protection too
In an interview with Managing IP, Alka Mehta, head of the formulation patent department at Indian pharmaceutical manufacturer Cipla, says that, notwithstanding its reputation as one of the world’s largest generics, companies such as Cipla also rely on patent protection in India and around the world
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
